Alkuttob, L., Aldib, L., Tamimi, M. A. A., Ateiwi, Y., Al-Ammouri, R., Al-Alwan, A., Zyoud, M. A., Yahia, L. A., Awidi, M. (2026). Second-generation H1 antihistamine use with survival and immune-related outcomes in lung cancer and melanoma patients receiving immune checkpoint inhibitors.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.11153